Sandoz Group (OTCMKTS:SDZNY) Shares Gap Down – Here’s What Happened
by Jessica Moore · The Cerbat GemShares of Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY – Get Free Report) gapped down before the market opened on Wednesday . The stock had previously closed at $83.75, but opened at $79.84. Sandoz Group shares last traded at $79.91, with a volume of 6,076 shares trading hands.
Analyst Ratings Changes
Separately, Barclays raised Sandoz Group to a “strong-buy” rating in a report on Monday, October 13th. One equities research analyst has rated the stock with a Strong Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy”.
Read Our Latest Analysis on Sandoz Group
Sandoz Group Stock Performance
The firm’s 50 day simple moving average is $74.40 and its 200-day simple moving average is $65.89. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.82 and a current ratio of 1.29.
About Sandoz Group
Sandoz Group (OTCMKTS:SDZNY) is a multinational pharmaceutical company focused on the development, manufacturing and commercialization of generic medicines and biosimilars. The company supplies off-patent small-molecule drugs as well as biologic alternatives intended to offer lower-cost therapeutic options across a range of clinical areas. Sandoz emphasizes access and affordability, positioning its portfolio to serve hospitals, pharmacies and health systems looking to expand patient access to essential therapies.
The company’s product offerings span conventional generics, complex and specialty generics, and a growing pipeline of biosimilar medicines.